Latest Financial Position News

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

VHM Limited has secured a significant offtake framework with Mitsui and a US$200 million financing interest from the US Export-Import Bank for its Goschen Rare Earths and Mineral Sands Project, alongside key environmental approvals. These milestones set the stage for a Final Investment Decision in the first half of 2026.

ActivEX Limited has completed a significant $800,000 share placement to True Creation Limited, aiming to strengthen its financial footing and advance exploration projects.

Bod Science reports a $576k cash outflow in Q1 FY2026 amid ongoing administration and delays in Biortica audit completion. The company plans a shareholder vote in November to approve its acquisition of Biortica and exit from administration.

Bod Science Limited reported a $576,000 net operating cash outflow for the September quarter, sustained by funding from Biortica Agrimed Limited under a Deed of Company Arrangement as it pursues a backdoor listing.

Kairos Minerals has raised approximately A$27 million through a premium share placement to fund drilling and development at its Mt York and Roe Hills gold projects in Western Australia, attracting robust demand from institutional investors.

Great Dirt Resources reports promising lithium soil anomalies in Western Australia's Pilbara region and progresses manganese exploration in New South Wales, supported by a solid cash position of $2.4 million.

Resolute Mining has agreed to support the sale of its 31.45 million shares in Loncor Gold to Chengtun Mining Group for C$1.38 per share, a move that will strengthen its balance sheet and accelerate key African projects.

Actinogen Medical has secured an initial $5.5 million R&D tax incentive rebate from the Australian Tax Office, with an additional $1.9 million pending, bolstering funding for its Alzheimer’s and depression drug trials.

29Metals maintains steady copper output at Golden Grove despite seismic disruptions to zinc production, while progressing key growth projects and regulatory steps toward Capricorn Copper’s restart.

29Metals reports a steady copper output but significant zinc production decline due to seismic disruptions at Golden Grove, alongside rising operational costs and ongoing progress at Capricorn Copper.

Sheffield Resources achieved a record quarterly concentrate production at its Thunderbird mine but faces subdued zircon sales due to challenging market conditions in China, withholding December quarter guidance.